SARS-CoV-2 infections have a long-term impact on the immune system: In a study recently published in the renowned journal “Allergy”, a MedUni Vienna research team shows that COVID-19 leads to considerable long-term changes in the immune system, even in mild cases. The findings could help to better understand the long-term consequences of an infection with […]
Read More… from Covid has long-term impact on the immune system
Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, six months after second doses, study finds. Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the […]
Read More… from Protection still high six months after second dose
Distinct immune response identified in the early phase of SARS CoV-2 infection: Infection with the SARS-CoV-2 virus leads to a unique response from the human immune system: a distinct pattern of immunological markers, unlike that of other viral respiratory diseases, is present in the blood of SARS-CoV-2 patients. This was shown in a recent study […]
Read More… from Distinct immune response identified in the early phase of SARS CoV-2 infection
Cellular immunity to SARS-CoV-2 found at six months in non-hospitalised individuals: Cellular (T cell) immunity against SARS-CoV-2 is likely to be present within most adults six months after primary infection, a new pre-print on bioRxiv suggests. The research from Public Health England and the UK Coronavirus Immunology Consortium (UK-CIC) demonstrates robust T cell responses to […]